Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tatsuki Ichikawa

Showing results (31-40 of 159) with videos related to

Pageof 16
Sort By:
Hepatology (Baltimore, Md.)|February 26, 2003
Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin geneHiroki Ishikawa, Kazuhiko Nakao, Kojiro Matsumoto, et al.
FEBS Letters|October 24, 2003
Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cellsKazuyuki Ohata, Tatsuki Ichikawa, Kazuhiko Nakao, et al.
Endocrinology|October 3, 2009
T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 miceIchiro Horie, Norio Abiru, Yuji Nagayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2012
Prevalence of restless legs syndrome in Japanese patients with chronic liver diseaseToshihisa Matsuzaki, Tatsuki Ichikawa, Hideaki Kondo, et al.
International Journal of Molecular Medicine|March 14, 2002
Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cellsTetsuhiko Arima, Kazuhiko Nakao, Keisuke Nakata, et al.
Internal Medicine (Tokyo, Japan)|May 7, 2016
Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver DiseaseHisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, et al.
Biomedical Reports|December 2, 2015
Predictive value of the efficacy of tolvaptan in liver cirrhosis patients using free water clearanceHisamitsu Miyaaki, Yutaka Nakamura, Tatsuki Ichikawa, et al.
BMC Gastroenterology|March 1, 2018
Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated miceTakemasa Senoo, Ryu Sasaki, Yuko Akazawa, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2011
Predictive value of the fibrosis scores in patients with chronic hepatitis C associated with liver fibrosis and metabolic syndromeHisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, et al.
Journal of Medical Case Reports|July 5, 2011
Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case reportMasaaki Hidaka, Mitsuhisa Takatsuki, Akihiko Soyama, et al.
Pageof 16

Showing results (31-40 of 159) with videos related to

Sort By:
Pageof 16
Hepatology (Baltimore, Md.)|February 26, 2003
Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin geneHiroki Ishikawa, Kazuhiko Nakao, Kojiro Matsumoto, et al.
FEBS Letters|October 24, 2003
Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cellsKazuyuki Ohata, Tatsuki Ichikawa, Kazuhiko Nakao, et al.
Endocrinology|October 3, 2009
T helper type 17 immune response plays an indispensable role for development of iodine-induced autoimmune thyroiditis in nonobese diabetic-H2h4 miceIchiro Horie, Norio Abiru, Yuji Nagayama, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 8, 2012
Prevalence of restless legs syndrome in Japanese patients with chronic liver diseaseToshihisa Matsuzaki, Tatsuki Ichikawa, Hideaki Kondo, et al.
International Journal of Molecular Medicine|March 14, 2002
Transactivation of human alpha-fetoprotein gene by X-gene product of hepatitis B virus in human hepatoma cellsTetsuhiko Arima, Kazuhiko Nakao, Keisuke Nakata, et al.
Internal Medicine (Tokyo, Japan)|May 7, 2016
Significance of Hepatic Insulin Clearance in Patients with Chronic Hepatitis C and Non-alcoholic Fatty Liver DiseaseHisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, et al.
Biomedical Reports|December 2, 2015
Predictive value of the efficacy of tolvaptan in liver cirrhosis patients using free water clearanceHisamitsu Miyaaki, Yutaka Nakamura, Tatsuki Ichikawa, et al.
BMC Gastroenterology|March 1, 2018
Geranylgeranylacetone attenuates fibrogenic activity and induces apoptosis in cultured human hepatic stellate cells and reduces liver fibrosis in carbon tetrachloride-treated miceTakemasa Senoo, Ryu Sasaki, Yuko Akazawa, et al.
Internal Medicine (Tokyo, Japan)|June 2, 2011
Predictive value of the fibrosis scores in patients with chronic hepatitis C associated with liver fibrosis and metabolic syndromeHisamitsu Miyaaki, Tatsuki Ichikawa, Naota Taura, et al.
Journal of Medical Case Reports|July 5, 2011
Living donor liver transplantation from a donor previously treated with interferon for hepatitis C virus: a case reportMasaaki Hidaka, Mitsuhisa Takatsuki, Akihiko Soyama, et al.
Pageof 16